ViraQuest, Inc. (now part of Antibodies Inc.) is a leading biotechnology company specializing in the rapid production of adenoviral vectors. Known for our innovative RAPAd® technology, we deliver custom adenovirus constructs with the fastest turnaround times in the industry—often in as little as three weeks. Our patented RAPAd® process combined with streamlined subcloning steps ensures high-quality constructs without the complications of revertants.
At ViraQuest, we’ve always believed in partnering with our clients to advance research success. With a focus on custom adenoviral services, including novel constructs, dual-expressing vectors, and amplifications, we are committed to providing the best materials and support for adenovirus-based research.
Now as part of Antibodies Inc., we continue to drive innovation, delivering cutting-edge adenoviral tools and solutions for the scientific community. Let our expertise and technology keep your research moving forward.
Company Details
- Founded
- -
- Address
- 25242 Co Rd 95, Davis,california 95616,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Davis, California
Viraquest Inc. Questions
Viraquest Inc.'s website is https://www.antibodiesinc.com/pages/adenovirus-production-services
Viraquest Inc.'s LinkedIn profile is https://www.linkedin.com/company/viraquest-inc-
Viraquest Inc.'s industry is
Biotechnology Research
Viraquest Inc.'s top competitors are
Immunochemistry Technologies, Llc,
Parexel,
Antibodies Incorporated,
Genabio Diagnostics.
Viraquest Inc.'s categories are Biotechnology Research
Viraquest Inc.'s founding year is 2001
